✦ LIBER ✦

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

✍ Scribed by Feliu, J; Salud, A; Escudero, P; Lopez-Gómez, L; Bolaños, M; Galán, A; Vicent, J-M; Yubero, A; Losa, F; De Castro, J; de Mon, M Á; Casado, E; González-Barón, M

Book ID: 118015073
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 121 KB
Volume: 94
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6603047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

669 PUBLICATION Capecitabine and oxalipl

669 PUBLICATION Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced / metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Chronomodulated administration of oxalip

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Phase 2 trial of oxaliplatin plus capeci

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

A phase II study of capecitabine plus 3-

A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

✍ Park, Y H; Kim, B-S; Ryoo, B-Y; Yang, S H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

636 POSTER Initial safety findings from

636 POSTER Initial safety findings from a phase III study of capecitabine (X) plus oxaliplatin (XELOX) vs. infusional 5-FU/LV plus oxaliplatin (FOLFOX-6) in first-line treatment of patients (pts) with metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 258 KB